Ozempic® provided greater weight reductions for adults with a baseline BMI ≥25kg/m2
Ozempic® (semaglutide) injection 0.5 mg or 1 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg, respectively, in adults with type 2 diabetes, regardless of baseline body mass index, with the greatest reductions occurring in adults with a baseline BMI ≥25 kg/m2. June 23, 2018